Lanzamiento Enero 2027

Ensayo controlado aleatorizado2004Financiación no declarada

Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state

Jellema A, Plat J, Mensink RP

European journal of clinical investigation · 103 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2004-11-01 · Eur J Clin Invest · vol. 34 · número 11 · págs. 766–773
Editorial
Wiley
Citado
144 citas · más que el 97% de estudios similares · 7.9× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
36 trabajos
Acceso
De pago
Áreas de investigación
Fatty Acid Research and Health · Adipokines, Inflammation, and Metabolic Diseases · Edible Oils Quality and Analysis
Palabras clave
obesity, weight loss, fish oil, omega-3 fatty acids, low-grade inflammation, interleukin-6, C-reactive protein, plasminogen activator inhibitor-1, TNF-α, soluble TNF receptors, postprandial inflammation, dietary intervention
MeSH
humans, obesity, weight loss, docosahexaenoic acids, eicosapentaenoic acid, fish oils, tumor necrosis factor-alpha, c-reactive protein, plasminogen activator inhibitor 1, receptors, tumor necrosis factor, interleukin-6, capsules, fasting, cross-over studies, double-blind method, postprandial period, dietary supplements, male, biomarkers

3 autores

  • Annemarie Jellema🇳🇱Maastricht University
  • Jogchum Plat🇳🇱Maastricht University
  • Ronald P. Mensink🇳🇱 · autor de correspondenciaMaastricht University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

In obese subjects, chronic low-grade inflammation contributes to an increased risk of metabolic abnormalities, which are reversed by weight loss. Sustained weight loss, however, is difficult to achieve and more insight into dietary approaches on anti-inflammatory responses in obese subjects is needed. In this respect, fish oil deserves attention.

Material and methods

Eleven obese men (BMI: 30-35 kg m(-2)) received daily fish oil (1.35 g n-3 fatty acids) or placebo capsules in random order for 6 weeks. Eight subjects continued with a weight reduction study that lasted 8 weeks. Mean weight loss was 9.4 kg. At the end of each experimental period a postprandial study was performed.

Results

Relative to fasting concentrations, interleukin-6 (IL-6) levels increased by 75% 2 h and by 118% 4 h after the meal (P < 0.001), when subjects consumed the control capsules. In contrast, C-reactive protein (C-RP) concentrations decreased slightly by 0.7% and 6.6% (P = 0.046), and those of plasminogen activator inhibitor-1 (PAI-1) antigen by, respectively, 26% and 53% (P < 0.001). Tumour necrosis factor-alpha (TNF-alpha; P = 0.330) and soluble TNF-receptor concentrations (sTNF-R55 and sTNF-R75; P = 0.451 and P = 0.108, respectively) did not change. Changes relative to fasting concentrations were not significantly affected by either fish oil or weight reduction. Absolute IL-6, C-RP, sTNF-R55, sTNF-R75, and PAI-1 antigen concentrations, however, were consistently lower after weight reduction, but not after fish oil consumption.

Conclusion

For slightly obese subjects a moderate intake of fish oil does not have the same favourable effects on markers for a low-grade inflammatory state as weight reduction.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.